Aktie A2PY53 GRAPEFRUIT USA, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Grapefruit USA, Inc.

Aktien

A2PY53

US3885981049

GPFT

Markt geschlossen - OTC Markets
Andere Börsenplätze
 17:35:18 28.06.2024 		% 5 Tage % 1. Jan.
0,001 USD 0,00 % Intraday Chart für Grapefruit USA, Inc. -9,09 % -23,08 %
2022 Grapefruit USA, Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2022 CI
2022 Der Hall of Fame Wrestler und Cannabis-Pionier Rob Van Dam führt die Cannabis-Marke RVD in Kalifornien durch einen Lizenzvertrag mit Grapefruit USA, Inc. ein CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Grapefruit USA, Inc. Provides Further Update on Diagnostic Lab Corporation Acquisition, Securing New Financing and Retail Store Plan
GRAPEFRUIT USA, INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
Grapefruit USA, Inc. Provides Further Update on Diagnostic Lab Corporation, Inc. Acquisition, Securing New Financing
GRAPEFRUIT USA, INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Grapefruit USA, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
GRAPEFRUIT USA, INC : Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year (form 8-K)
Hall of Fame Wrestler and Cannabis Pioneer Rob Van Dam to Launch RVD Cannabis Brand in California Through Licensing Deal with Grapefruit USA, Inc.
Hall of Fame Wrestler and Cannabis Pioneer Rob Van Dam to Launch RVD Cannabis Brand in California Through Licensing Deal with Grapefruit USA, Inc
GRAPEFRUIT USA, INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Grapefruit USA, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Grapefruit USA, Inc. Provides Update on Diagnostic Lab Corporation, Inc. Acquisition, Secures New Financing
Grapefruit USA, Inc. Executes Binding Letter of Intent to Acquire Diagnostic Lab Corporation, Inc., Secure New Financing
GRAPEFRUIT USA, INC : Entry into a Material Definitive Agreement (form 8-K)
GRAPEFRUIT USA, INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Grapefruit USA, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Grapefruit USA, Inc. Issues Update on Proposed Strategic Acquisition
Grapefruit USA, Inc. California Cannabis Distributor License Renewed in Record Time
California Department of Cannabis Control Renews Grapefruit USA's California Cannabis Distributor License by May 13, 2023
Health Canada Approves NNCP for Grapefruit USA, Inc. Hourglass™ Time Release THC+CBD Delivery Cream
Health Canada Approves NNCP for Grapefruit USA, Inc. Hourglass Time Release THC+CBD Delivery Cream
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2PY53 Aktie
  4. Nachrichten Grapefruit USA, Inc.
  5. Andere Sprachen